Pharma Journalist, Author at Pharma Journalist - Page 6 of 910

Novartis Reports Positive Phase III Results for Remibrutinib in MS

Biocytogen Licenses VHH Antibody to Qilu for Neuroscience Research

Typewriter Therapeutics Launches With $56 Million Series A

World ADC Awards 2026 Shortlist Announced, Recognizing Excellence Across the ADC Industry

Cipla Licenses HER2 Cancer Drug TQB2102 Across Emerging Markets

FDA Approves BESREMi for Essential Thrombocythemia After 30 Years

Teva Discusses Lower Medicaid Drug Prices With Trump Administration

Kazia Therapeutics Raises $40 Million to Advance Paxalisib Trials

SK Biopharmaceuticals to In-License Opakalim for Epilepsy Treatment

FDA Accepts Kowa’s K-911 Glaucoma Drug Application for Review